Bleichroeder LP Curis Inc Transaction History

Bleichroeder LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.51 - $0.78 $31,682 - $48,455	-62,122 Reduced 19.9%	250,000 $150,000
Q4 2022 Feb 13, 2023	SELL	$0.47 - $17.22 $58,682 - $2.15 Million	-124,856 Reduced 28.57%	312,122 $171,000
Q2 2022 Aug 10, 2022	BUY	$0.71 - $2.43 $35,500 - $121,500	50,000 Added 12.92%	436,978 $430,000
Q1 2022 May 11, 2022	BUY	$2.31 - $5.13 $173,250 - $384,750	75,000 Added 24.04%	386,978 $921,000
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $219,499 - $320,000	25,000 Added 8.71%	311,978 $3.53 Million
Q4 2020 Feb 10, 2021	BUY	$1.08 - $8.2 $309,936 - $2.35 Million	286,978 New	286,978 $2.35 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

Stay updated on Bleichroeder LP with notifications on news.